Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.83 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10870776 | 1.00 | HPGD (1.00) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL10871888 | 0.94 | HPGD (0.89) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL10871219 | 0.94 | HPGD (0.89) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL12256962 | 0.94 | HPGD (0.89) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL1755726 | 0.91 | HPGD (1.00) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL835108 | 0.91 | HPGD (1.00) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL13398131 | 0.90 | HPGD (0.81) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL10873840 | 0.89 | HPGD (0.79) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL10873836 | 0.89 | HPGD (0.79) | HPGDALDH1A1LMNAL3MBTL1MAPT | |
| SCHEMBL10872100 | 0.89 | HPGD (0.79) | HPGDALDH1A1LMNAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 610 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118119253-A | Composite material, preparation method thereof and light-emitting device | 广东聚华新型显示研究院 | 2024-05-31 | — | — | CN | claimed |
| CN-110922346-A | Tris (4-acetyldiphenyl sulfide) thioylium hexafluorophosphate and synthesis method thereof | 上海鑫响实业有限公司 | 2020-03-27 | — | — | CN | claimed |
| US-7375144-B2 | Abrasion resistant coatings | EASTMAN CHEMICAL COMPANY (US) | 2008-05-20 | — | — | US | claimed |
| EP-1891169-A1 | ABRASION RESISTANT COATINGS | EASTMAN CHEMICAL COMPANY (US) | 2008-02-27 | — | — | EP | claimed |
| WO-2006138198-A1 | ABRASION RESISTANT COATINGS | EASTMAN CHEMICAL COMPANY (US) | 2006-12-28 | — | — | WO | claimed |
| US-20060286383-A1 | ABRASION RESISTANT COATINGS | EASTMAN CHEMICAL COMPANY (US) | 2006-12-21 | — | — | US | claimed |
| CN-122080822-A | Pressure-sensitive epoxy adhesive composition and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | TORAY INDUSTRIES, INC. (JP) | 2026-03-19 | — | — | US | disclosed |
| CN-121338770-A | Catalyst for preparing 4-acetyl diphenyl sulfide and application thereof | 湖北远大富驰医药化工股份有限公司 | 2026-01-16 | — | — | CN | disclosed |
| CN-121338770-A | Catalyst for preparing 4-acetyl diphenyl sulfide and application thereof | 湖北远大富驰医药化工股份有限公司 | 2026-01-16 | — | — | CN | disclosed |
| US-12264120-B2 | Amine synergists with UV—a absorption | SUN CHEMICAL CORPORATION (US) | 2025-04-01 | — | — | US | disclosed |
| EP-4301725-B1 | AMINE SYNERGISTS WITH UV-A ABSORPTION | SUN CHEMICAL CORP (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240270678-A1 | AMINE SYNERGISTS WITH UV-A ABSORPTION | SUN CHEMICAL CORPORATION (US) | 2024-08-15 | — | — | US | disclosed |
| US-4968702-A | ANTIARTHRITIC, INHIBITORS OF PROGRESSIVE JOINT DETERIORATION, IMMUNOSUPPRESSANT | AMERICAN CYANAMID COMPANY (US) | 1990-11-06 | — | — | US | disclosed |
| EP-0379145-A2 | Substituted quinolinecarboxylic acids | AMERICAN CYANAMID COMPANY (US) | 1990-07-25 | — | — | EP | disclosed |
| EP-0192167-A1 | Use of thio-substitued ketones as photoinitiators | MERCK PATENT GmbH (DE) | 1986-08-27 | — | — | EP | disclosed |
| US-4536517-A | ANTIDIABETIC, ANTILIPEMIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1985-08-20 | — | — | US | disclosed |
| US-4251341-A | DIALKOXY-ACETYL DERIVATIVES OF AROMATIC COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1981-02-17 | — | — | US | disclosed |
| US-4055652-A | 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof | SYNTEX (U.S.A.) INC. (US) | 1977-10-25 | — | — | US | disclosed |
| US-3933793-A | BACTERICIDES, VIRICIDES | RECORDATI S.A. CHEMICAL AND PHARMACEUTICAL COMPANY (CH) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12264120-B2 | Amine synergists with UV—a absorption | OR51E2, PNMT, ALDH7A1 | HPGD 377/4885ALDH1A1 11/4885LMNA 2858/4885 |
| US-20240270678-A1 | AMINE SYNERGISTS WITH UV-A ABSORPTION | ALDH7A1, PNMT, OR51E2 | HPGD 355/4885ALDH1A1 8/4885LMNA 2210/4885 |
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | PPA1, PHOSPHO1, PHPT1 | HPGD 2876/4885ALDH1A1 637/4885LMNA 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.